Dataset: 11.1K articles from the COVID-19 Open Research Dataset (PMC Open Access subset)
All articles are made available under a Creative Commons or similar license. Specific licensing information for individual articles can be found in the PMC source and CORD-19 metadata
.
More datasets: Wikipedia | CORD-19

Logo Beuth University of Applied Sciences Berlin

Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin

Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)

Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies

Imprint / Contact

Results for Query ‹ Bacterial pneumonia medication

The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections – 5. Why are Diagnostics Important for LRTIs? (Antibiotic Stewardship)

Severe Pulmonary Infection in a 20-Month-Old Female – 3.3. Management of Empyema

Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children – Conclusions

Severe Pulmonary Infection in a 20-Month-Old Female – 3.4. Procedural Intervention in Management of Empyema

Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia – Synergistic actions of antibodies with antibiotics mitigate pulmonary tissue damage and edema and prolong the survival of mice with secondary bacterial pneumonia.

Antibody Treatment against Angiopoietin-Like 4 Reduces Pulmonary Edema and Injury in Secondary Pneumococcal Pneumonia – Immunoneutralization of pneumococcal pneumolysin abrogates its pore-forming action on alveolar epithelium.

Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases – Monitoring Treatment of Pyothorax

Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases – Treatment of Pyothorax in Dogs and Cats

The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections – 3. How to Differentiate Bacterial from Viral LRTI at the Point of Care?

Viral Infection Is Not Uncommon in Adult Patients with Severe Hospital-Acquired Pneumonia – Ethics Statement

Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship – Conclusions

Virus-induced secondary bacterial infection: a concise review – Prevention of secondary bacterial infection

Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship – Clinical outcomes

Viral Infection Is Not Uncommon in Adult Patients with Severe Hospital-Acquired Pneumonia – Study Setting

Respiratory virus of severe pneumonia in South Korea: Prevalence and clinical implications – Clinical impact of virus detection

The changes of prevalence and etiology of pediatric pneumonia from National Emergency Department Information System in Korea, between 2007 and 2014 – Materials and methods

Impact of preceding respiratory viral infections on the clinical severity of patients with pneumococcal pneumonia – Antimicrobial treatment and clinical outcome

Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy – 5. Treatment

Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial – Discussion

Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults – Endpoints

Virus-induced secondary bacterial infection: a concise review – Conclusion

Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy – 6. Conclusions

Community-acquired pneumonia in children — a changing spectrum of disease – Management — recent advances

Inflammatory response in mixed viral-bacterial community-acquired pneumonia – Pre-publication history

Respiratory failure presenting in H1N1 influenza with Legionnaires disease: two case reports – Conclusions